| Literature DB >> 27544449 |
Santosh Kumar Adla1, Barbora Slavikova1, Marketa Smidkova1, Eva Tloustova1, Martin Svoboda1, Vojtech Vyklicky2, Barbora Krausova2, Pavla Hubalkova3, Michaela Nekardova4, Kristina Holubova2, Karel Vales2, Milos Budesinsky1, Ladislav Vyklicky2, Hana Chodounska1, Eva Kudova5.
Abstract
Herein, we report a new class of amide-based inhibitors (1-4) of N-methyl-d-aspartate receptors (NMDARs) that were prepared as analogues of pregnanolone sulfate (PAS) and pregnanolone glutamate (PAG) - the steroidal neuroprotective NMDAR inhibitors. A series of experiments were conducted to evaluate their physicochemical and biological properties: (i) the inhibitory effect of compounds 3 and 4 on NMDARs was significantly improved (IC50=1.0 and 1.4μM, respectively) as compared with endogenous inhibitor - pregnanolone sulfate (IC50=24.6μM) and pregnanolone glutamate (IC50=51.7μM); (ii) physicochemical properties (logP and logD) were calculated; (iii) Caco-2 assay revealed that the permeability properties of compounds 2 and 4 are comparable with pregnanolone glutamate; (iv) compounds 1-4 have minimal or no adverse hepatic effect; (v) compounds 1-4 cross blood-brain-barrier.Entities:
Keywords: Amide; Blood-brain-barrier permeability; Caco-2 assay; NMDA receptor; Neurosteroid; Structure-activity relationship
Mesh:
Substances:
Year: 2016 PMID: 27544449 DOI: 10.1016/j.steroids.2016.08.010
Source DB: PubMed Journal: Steroids ISSN: 0039-128X Impact factor: 2.668